Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05021133 · ClinicalTrials.gov registry record · NA
Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT05021133 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 22 participants.
The verdict
NCT05021133, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.
Interventions
- BEHAVIORAL Tele-Navi LCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-06-05 |
| Est. Completion | 2025-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05021133
The ClinicalTrials.gov registry entry for NCT05021133 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tele-Navi LCS is the first listed.
NCT05021133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05021133 about?
NCT05021133 is a clinical study titled "Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)". Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening...
What is the current status of trial NCT05021133?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2023-06-05. Estimated completion is 2025-12-12.
What interventions are being tested in trial NCT05021133?
The interventions under investigation include: Tele-Navi LCS (BEHAVIORAL).
Who is sponsoring clinical trial NCT05021133?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.